Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ELTEK LTDELTK · Entity 7171 | Director | March 18, 2026 | March 18, 2026 |
| Nano-X Imaging Ltd.NNOX · Entity 7098 | Director · Chief Executive Officer | September 15, 2026 | September 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ELTEK LTD
Report date March 18, 2026 · Filed March 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $5.89 · Expires 2031-09-06 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-18 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on September 6, 2021 |
| Employee Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $8.67 · Expires 2033-10-06 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-18 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F2: The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on October 10, 2023 |
Filing footnotes · ownership attribution and instrument terms
F1: The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on September 6, 2021
F2: The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on October 10, 2023
Nano-X Imaging Ltd.
Report date September 15, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | IndirectBy a wholly owned company | 65,443 |
Reported balance
After 2026-09-15 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-09-15 · Purchase · Acquired 10,000 · Balance 65,443 F1: The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 60,584 |
Reported balance
Holding disclosure · report date 2026-09-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 60,584 F2: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. |
| Stock Option (right to buy ordinary shares)SEC Table II · derivative / convertible security · Conversion / exercise price $2.21 · Expires 2030-02-11 | Direct | 40,234 |
Reported balance
Holding disclosure · report date 2026-09-15 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 40,234 F2: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. F3: The options reported in this row were granted to the Reporting Person by the Issuer on February 11, 2020 and are fully vested and exercisable as of the date of this report. |
| Stock Option (right to buy ordinary shares)SEC Table II · derivative / convertible security · Conversion / exercise price $23.84 · Expires 2032-01-02 | Direct | 300,000 |
Reported balance
Holding disclosure · report date 2026-09-15 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 300,000 F2: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. F4: The options reported in this row were granted to the Reporting Person by the Issuer on January 2, 2020 and are fully vested and exercisable as of the date of this report. |
| Stock Option (right to buy ordinary shares)SEC Table II · derivative / convertible security · Conversion / exercise price $11.52 · Expires 2034-04-16 | Direct | 150,000 |
Reported balance
Holding disclosure · report date 2026-09-15 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 150,000 F2: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. F5: The options reported in this row were granted to the Reporting Person by the Issuer on April 16, 2024, and vest and become exercisable in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested on the four-year anniversary of that grant date (April 16, 2028). |
Filing footnotes · ownership attribution and instrument terms
F1: The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person.
F2: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
F3: The options reported in this row were granted to the Reporting Person by the Issuer on February 11, 2020 and are fully vested and exercisable as of the date of this report.
F4: The options reported in this row were granted to the Reporting Person by the Issuer on January 2, 2020 and are fully vested and exercisable as of the date of this report.
F5: The options reported in this row were granted to the Reporting Person by the Issuer on April 16, 2024, and vest and become exercisable in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested on the four-year anniversary of that grant date (April 16, 2028).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2026 Filed Sep 16, 2026 10:14 UTC | Nano-X Imaging Ltd. NNOX · Entity 7098 | PurchaseOrdinary Shares | 10,000 | $0.69 | $6,900.00 |
DisclosureSEC source: 0001213900-26-100307 · ownership.xml · nonDerivative · entry 1 Meltzer Erez · CIK 0001371973 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By a wholly owned company Disclosed balance after: 65,443 F1 · security: The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person. F1 · ownership.nature: The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 11:59 UTC | Nano-X Imaging Ltd. NNOX · Entity 7098 | PurchaseOrdinary Shares | 10,000 | $0.78 | $7,800.00 |
DisclosureSEC source: 0001213900-26-099455 · ownership.xml · nonDerivative · entry 1 Meltzer Erez · CIK 0001371973 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By a wholly owned company Disclosed balance after: 55,443 F1 · security: The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person. F1 · ownership.nature: The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person. Read SEC document |
| August 10, 2026 Filed Aug 11, 2026 13:24 UTC | Nano-X Imaging Ltd. NNOX · Entity 7098 | PurchaseOrdinary Shares | 9,443 | $1.03 | $9,726.29 |
DisclosureSEC source: 0001213900-26-087547 · ownership.xml · nonDerivative · entry 1 Meltzer Erez · CIK 0001371973 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By a wholly owned company Disclosed balance after: 45,443 F1 · security: The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person. F1 · ownership.nature: The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person. Read SEC document |
| July 27, 2026 Filed Jul 28, 2026 20:54 UTC | Nano-X Imaging Ltd. NNOX · Entity 7098 | PurchaseOrdinary Shares | 36,000 | $0.93 | $33,480.00 |
DisclosureSEC source: 0001213900-26-082326 · ownership.xml · nonDerivative · entry 1 Meltzer Erez · CIK 0001371973 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By a wholly owned company Disclosed balance after: 36,000 F1 · ownership.nature: The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.